Society of Thoracic Surgeons 53rd Annual Meeting

Slides:



Advertisements
Similar presentations
Pulmonary Atresia and Intact Ventricular Septum
Advertisements

Making Sense of Longitudinal Data Changes in ventricular function in babies with a functional single ventricle Travis Wilder, M.D. CHSS Data Center Kirklin-Ashburn.
HOW I DO IT ? MODIFIED NORWOOD’S OPERATION
Ultra long term outcomes in adult survivors of tetralogy of Fallot and the effect of pulmonary valve replacement Dobson R1,2, Danton M2, Walker N2, Tzemos,
Tetralogy of Fallot, Pulmonary Atresia, with MAPCAs Technique for Early Complete Repair Frank Hanley.
Palliative Operation Seoul National University Hospital Department of Thoracic & Cardiovascular Surgery.
AATS/STS Congenital Heart Disease Symposium: Unsettled and Unanswered Questions in Congenital Heart Surgery Lessons Learned from the SVR Trial: Update.
Unsettled and Unanswered Questions Christopher Caldarone AATS symposium April 26 th, 2015.
One & A Half Ventricle Repair
RDB Jaquiss Duke University
Pulmonary Atresia with Intact Ventricular Septum Ali Sepahdari, MD University of Illinois at Chicago.
Bidirectional Cavo-pulmonary Anastomosis Seoul National University Hospital Department of Thoracic & Cardiovascular Surgery.
Congenital Heart Lesions
STS – CHSS Link Marshall L. Jacobs, M.D. Jeffrey P. Jacobs, M.D. Johns Hopkins University Do This Immediately Do not Save this template. Use File…Save.
Long-Term Mortality After the Fontan Operation: Twenty Years of Experience at a Single Center Tacy E. Downing, Kiona Y. Allen, Andrew C. Glatz, Lindsay.
Fontan Procedure Ken Jusko, DO. Case 39 yo female with h/o tricuspid atresia and A. fib. and prior Fontan. No prior studies available for comparison.
Double Inlet Ventricle Seoul National University Hospital Department of Thoracic & Cardiovascular Surgery.
Lessons Learned from the Society of Thoracic Surgeons (STS) Congenital Database September 25, 2015 Robert J. Dabal, MD Associate Professor of Surgery.
Congenital Heart Surgeon Society Atrioventricular Septal Defect prospective inception cohort Webinar Series.
95th Annual Meeting: American Association for Thoracic Surgery
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Year in Cardiovascular Surgery J Am Coll Cardiol.
Joseph A. Sclafani MD1,2, Kevin Liang PhD 2, Choll W Kim MD,PhD1
James S. Tweddell, MD Warren W. Bailey Endowed Chair,
Ebstein Anomaly Cohort: Update
Background Post-transplant outcomes in adult Fontan patients remain poorly defined. Available studies limited to sub-groups within published registry data.
CHSS Fall Work Weekend November 18, 2016
The Optimal Timing of Stage-2-Palliation after the Norwood Operation: A Multi-Institutional Analysis from the CHSS CHSS Fall Work Weekend November 19,
Pirooz Eghtesady and Tara Karamlou, and Members of the Working Group
Congenital Heart Disease
Cardiac Manifestation of DiGeorge Syndrome
Xinwei Du M.D. Shanghai Children’s Medical Center
Late Follow-Up from the PARTNER Aortic Valve-in-Valve Registry
The impact of a dedicated single-ventricle home-monitoring program on interstage somatic growth, interstage attrition, and 1-year survival  Christopher.
European Heart Association Journal 2007 April
Work Weekend, Toronto November 18-20, 2016
Pulmonary atresia with intact ventricular septum: Predictors of early and medium-term outcome in a population-based study  Piers E.F. Daubeney, MRCP,
Robert J. Steffen, MD, Eugene H. Blackstone, MD, Nicholas G
Factors influencing early and late outcome of the arterial switch operation for transposition of the great arteries  Gil Wernovsky, MD* (by invitation),
Initial Experience With Hybrid Palliation for Neonates With Single-Ventricle Physiology  Christopher A. Caldarone, MD, Lee Benson, MD, Helen Holtby, MD,
Eric M. Graham, MD, Sinai C. Zyblewski, MD, Jacob W
The Optimal Timing of Stage-2-Palliation After the Norwood Operation
Hypertrophic Cardiomyopathy in Childhood: Disease Natural History, Impact of Obstruction, and Its Influence on Survival  Edward J. Hickey, MD, Brian W.
Risk Factors for Mortality After the Norwood Procedure Using Right Ventricle to Pulmonary Artery Shunt  Shunji Sano, MD, Shu-Chien Huang, MD, Shingo Kasahara,
Lesion-specific outcomes in neonates undergoing congenital heart surgery are related predominantly to patient and management factors rather than institution.
Surgical management of competing pulmonary blood flow affects survival before Fontan/Kreutzer completion in patients with tricuspid atresia type I  Travis.
Results of palliation with an initial pulmonary artery band in patients with single ventricle associated with unrestricted pulmonary blood flow  Bahaaldin.
Evolving strategies and improving outcomes of the modified Norwood procedure: a 10- year single-institution experience  Anthony Azakie, MD, Sandra L Merklinger,
Results of Primary Repair Versus Shunt Palliation in Ductal Dependent Infants With Pulmonary Atresia and Ventricular Septal Defect  Bahaaldin Alsoufi,
Outcomes of heart transplantation in children with hypoplastic left heart syndrome previously palliated with the Norwood procedure  Bahaaldin Alsoufi,
Natural History of Pulmonary Atresia With Intact Ventricular Septum and Right- Ventricle–Dependent Coronary Circulation Managed by the Single-Ventricle.
No Financial Disclosure or Conflict of Interest
Travis J. Wilder, MD, Brian W. McCrindle, MD, Edward J
Clinical experience with an implantable, intracardiac, continuous flow circulatory support device: physiologic implications and their relationship to.
Impact of Patient Characteristics and Anatomy on Results of Norwood Operation for Hypoplastic Left Heart Syndrome  Bahaaldin Alsoufi, MD, Makoto Mori,
Intermediate-term mortality and cardiac transplantation in infants with single-ventricle lesions: Risk factors and their interaction with shunt type 
Biventricular strategies for neonatal critical aortic stenosis: High mortality associated with early reintervention  Edward J. Hickey, MD, Christopher.
Supplement, Optimal Timing of Stage 2
Profiles of hemodynamics and oxygen transport derived by using continuous measured oxygen consumption after the Norwood procedure  Jia Li, MD, PhD, Gencheng.
Influence of Morphology and Initial Surgical Strategy on Survival of Infants With Tricuspid Atresia  Bahaaldin Alsoufi, MD, Brian Schlosser, BS, RDCS,
Surgical management of aortopulmonary window associated with interrupted aortic arch: A Congenital Heart Surgeons Society study  Igor E. Konstantinov,
Palliation Outcomes of Neonates Born With Single-Ventricle Anomalies Associated With Aortic Arch Obstruction  Bahaaldin Alsoufi, MD, Courtney McCracken,
Yasutaka Hirata, MD, Jonathan M. Chen, MD, Jan M
André Rüffer, MD, Florian Arndt, MD, Sergej Potapov, MS, Thomas S
Intermediate survival in neonates with aortic atresia: A multi-institutional study  Marshall L. Jacobs, MD, Eugene H. Blackstone, MD, Leonard L. Bailey,
Truncus Arteriosus Associated with Interrupted Aortic Arch in 50 Neonates: A Congenital Heart Surgeons Society Study  Igor E. Konstantinov, MD, PhD, Tara.
Older children at the time of the Norwood operation have ongoing mortality vulnerability that continues after cavopulmonary connection  Bahaaldin Alsoufi,
Modified Fontan without use of cardiopulmonary bypass
Atlantic Cardiovascular Patient Outcomes Research Team
Eleanor T. Ross, MD, John M. Costello, MD, MPH, Carl L
Estimating Mortality Risk for Adult Congenital Heart Surgery: An Analysis of The Society of Thoracic Surgeons Congenital Heart Surgery Database  Stephanie.
Presentation transcript:

Society of Thoracic Surgeons 53rd Annual Meeting The Optimal Timing of Stage-2-Palliation after the Norwood Operation: A Multi-Institutional Analysis from the Congenital Heart Surgeons’ Society 8 minute presentation! Society of Thoracic Surgeons 53rd Annual Meeting January 23, 2017 JM Meza, EJ Hickey, BW McCrindle, EH Blackstone, BR Anderson, DM Overman, JK Kirklin, CA Caldarone, KJ Guleserian, RW Kim, WM DeCampli, ML Jacobs, ME Mitchell, P Chai, WG Williams, RDB Jaquiss

We have no disclosures.

Mortality during Staged Palliation Mortality remains high through single ventricle palliation Especially after the Norwood operation and prior to Stage-2- Palliation (S2P) Timing of S2P Physician modifiable Effect of timing of S2P not well understood Often due to intrinsinc patient factors that are not modifiable

Timing of S2P is a complex decision Earlier S2P Reduce volume load on systemic ventricle Eliminate shunt-associated risks Normalize coronary blood flow in those with BT shunt Normalize pulmonary vascular flow and pressure Underdevelopment of pulmonary vasculature Failure of PVR to decrease Later S2P Growth of infant and pulmonary vasculature Potentially decreased resource utilization Increased exposure to risks of Norwood-associated physiology

Hypothesis An optimal timing exists Norwood S2P Fontan ? An optimal timing exists Is based on patient-specific characteristics

Study Population Data Source = CHSS Critical Left Ventricular Outflow Tract Obstruction Registry Neonate ≤ age 30 days at admission to a CHSS institution 2005 onward AV & VA concordance Precludes an adequate systemic cardiac output through the aortic valve Study inclusion criteria Initial post-natal intervention = Norwood operation

Patients and Outcomes

Risk Factors for Death after Norwood Multiphase parametric risk hazard analysis

Outcomes after S2P

Progressing to S2P 1.7-17.2 months old

Risk Factors for Death after S2P

Analyzing Staged Procedures Norwood S2P 4 Years Model 1 Model 2 Parametric conditional survival analysis CS = S(t|s) = S(4 years | S2P) Analysis of Timing 4-year survival vs. age at S2P

Survival After Norwood %

Survival after Norwood, through S2P %

Survival through S2P Probability of Survival Months since Norwood Survival at 4 years = 71±5% Probability of Survival COHORT AVERAGE Months since Norwood

post-Norwood Survival Optimal Timing, by Age Risk-adjusted, 4-Year, post-Norwood Survival Age at S2P (months) “Cohort average”

Optimal Timing, by Age Across various risk profiles Low risk Average-risk Risk-adjusted, 4-Year, post-Norwood Survival High risk Age at S2P (months)

post-Norwood Survival Optimal Timing, by WAZ -5 -4 -3 -2 -1 0 1 2 3 4 5 Risk-adjusted, 4-Year, post-Norwood Survival Weight-for-Age Z-score at the pre-S2P cath “Cohort average”

Optimal Timing, by WAZ Across various risk profiles Risk-adjusted, 4-Year, post-Norwood Survival Weight-for-Age Z-score at the pre-S2P cath -5 -4 -3 -2 -1 0 1 2 3 4 5 Low risk Average-risk High risk

Clinical Implications Low- and average-risk infants Develop or modification of protocols Reduce variability across centers High-risk infants Does not rescue - survival especially poor with early S2P No age/weight changes risk profile Early referral for heart transplantation may maximize survival